Polo Shirts Black And White
HAYWARD, Calif., June 13, 2014 /PRNewswire/ Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, today announced the appointment of Dr. Philip Sager, MD, FACC, FAHA, FHRS, to its Board of Directors.
Effective at Anthera's Annual General Meeting held on June 10, 2014 Dr. Bogdan Dziurzynski has retired from Anthera's Board of Directors. Dr. Dziurzynski joined the Anthera Board of Directors in 2012.
since 2011, a private pharmaceutical, device and diagnostics consultant since 2010 and Member of the Scientific Programs Committee, the Scientific Oversight Committee, and the Executive Committee of the Cardiac Safety Research Consortium since 2006, serving as Chair of the Scientific Programs Committee and Scientific Oversight Committee at various times. From 2009 through 2010 Dr. Sager was Vice President, Clinical Research and Head, CV/Metabolic Development for Gilead Sciences, a biotechnology company. Dr. degrees in chemistry and biology from the Massachusetts Institute of Technology
Help employers find you! Check out all the .
Anthera Pharmaceuticals Inc Appoints Dr Philip Sager To Boa
Anthera Pharmaceuticals, Inc. (ANTH) Announces Personnel Changes AstraZeneca PLC (AZN) Investors Still Want To Link Executive Pay To Pipeline Delivery
Anthera Pharmaceuticals, Inc. (ANTH) Reports 2013 Fourth Quarter And Fiscal Year Financial Results And Operational Update Financially Troubled Dendreon Corporation (DNDN) Loses Its CEO
"Anthera is entering an exciting time as it accelerates its clinical studies in lupus and IgA nephropathy," said Dr. Sager. "I look forward to working with the Anthera Board and experienced senior management team as they execute the clinical and regulatory activities necessary to further advance the blisibimod development program."
Safe Harbor Statement
SOURCE Anthera Pharmaceuticals, Inc.
Anthera Pharmaceuticals, Inc. (ANTH) Reports 2013 Third Quarter Financial Results, Clinical and Regulatory Update Novartis AG (NVS) Appoints Merck Co., Inc. (MRK) Executive As Cancer Chief Polo Shirts Black And White
industry experience in drug development will offer us a great perspective as we continue to navigate the evolving FDA regulatory landscape," said Dr. Chris Henney, Chairman of Anthera Pharmaceuticals. "We look forward to taking advantage of his insight and strategic guidance as we further advance Anthera's late stage clinical trials."
"We are pleased to welcome Dr. Sager to our board of directors. Philip's extensive global regulatory expertise and Fred Perry Plain White Polo
Any statements contained in this press release that refer to future events or other non historical matters, including statements that are preceded by, followed by, or that include such words as "estimate," "intend," "anticipate," "believe," "plan," "goal," "expect," "project," or similar statements, are forward looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward looking statements Womens Plain Polo Shirts Uk
Anthera Pharmaceuticals, Inc. (ANTH) Reports 2014 First Quarter Financial Results And Operational Update Amgen (AMGN) Brings In Ex 3M Company (MMM) CFO Meline As Finance Chief
Dr. Sager is a Fellow of the American College of Cardiology, a Fellow of the American Heart Association and a Fellow of the Heart Rhythm Society. Dr. Sager has served as a Consulting Professor of Medicine at the Stanford University School of Medicine since 2013, a Full Voting Member of the United States Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee Lacoste Polo Sale Uk
"Bogdan's guidance in navigating a multitude of challenges has been invaluable over the past two years," said Dr. Chris Henney. "The management team and Board of Directors are grateful for his guidance and wish him all the best."
are based on Anthera's expectations as of the date of this press release and are subject to certain risks and uncertainties that could cause actual results to differ materially as set forth in Anthera's public filings with the SEC, including Anthera's Annual Report on Form 10 K for the year ended December 31, 2013and Quarterly Report on Form 10 Q for the quarter ended March 31, 2014. Anthera disclaims any intent or obligation to update any forward looking statements, whether because of new information, future events or otherwise, except as required by applicable law.
Polo Shirts Black And White
Embroidered Polo Shirts Uk
Beats By Dre Powerbeats 2 Wireless
Beats Iphone 7
Polo Shirts Embroidered Sydney
Polo Lacoste 2018
Lacoste Jeans Mens
Lacoste Pique Polo Shirt Sale
Beats Earphones Wallpaper
Lacoste Polo White
Ghd Natural Bristle Radial Brush Size 4 (55mm Barrel)
Fred Perry Long Sleeve Polo Womens
Lacoste Yellow Shirt
Embroidered Polo Shirts Cheap
Beats Portable Speaker
Fred Perry Raincoat